代谢抑制药物对药物不良反应发生的定量影响:一种后向选择方法
本研究利用ADRED前瞻性多中心队列中急诊入院ADR数据,构建通路抑制负荷评分,通过二元逻辑回归后向选择识别与跌倒和出血显著正相关的代谢通路。跌倒相关通路为CYP2D6、OCT2和羧酸酯酶1;出血相关通路为CYP2C19、CYP3A4、MRP4、OAT2、OATP1B1和羧酸酯酶1。结论提示高通路抑制负荷可能促成ADR发生,需在第二数据集进一步验证。
要点
- 跌倒相关抑制通路:CYP2D6、OCT2和羧酸酯酶1。
- 出血相关抑制通路:CYP2C19、CYP3A4、MRP4、OAT2、OATP1B1和羧酸酯酶1。
- 通路抑制负荷评分可用于个体化评估合并用药的ADR风险。
核心结论
- 通路抑制负荷评分可识别与跌倒和出血相关的代谢通路,提示高抑制负荷可能促成ADR发生。
- 研究结果需在第二数据集进一步验证。
研究设计与样本
- 基于ADRED前瞻性多中心队列中急诊入院ADR数据(试验注册号DRKS00008979)的回顾性分析。
- 实施通路抑制负荷评分系统计算每位患者的个体负荷,并以累积负荷评分作为二元逻辑回归的预测因子进行后向选择。
主要发现
- 跌倒方面,CYP2D6、OCT2和羧酸酯酶1被识别为具有累积抑制负荷的相关代谢通路。
- 出血方面,CYP2C19、CYP3A4、MRP4、OAT2、OATP1B1和羧酸酯酶1被确定为相关通路。
- 在跌倒相关通路中发现了常见跌倒风险增加药物及相关药物,在出血相关通路中发现了致出血药物。
临床怎么用
- 临床药师可参考通路抑制负荷评分,在个体层面评估合并用药对代谢通路的抑制负担。
- 对使用CYP2D6、OCT2或羧酸酯酶1抑制药物的患者,应关注跌倒风险。
- 对使用CYP2C19、CYP3A4、MRP4、OAT2、OATP1B1或羧酸酯酶1抑制药物的患者,应关注出血风险。
局限性
- 研究结果需在第二数据集进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: The quantitative effect of several inhibitory drugs on the development of adverse drug reactions (ADRs) is currently difficult to estimate. Our aim was to identify metabolic pathways, which, when inhibited, increase the risk for certain ADRs, and to use this system to consider comedication at individual level. METHODS: Data of a prospective multicentre cohort of ADRs on emergency department admissions were used (ADRED-study, trial registration: DRKS00008979). A score system to rate the burden of inhibition on pathways was implemented to calculate individual burdens per patient. These cumulative burden scores were used as predictors in binary logistic regressions to identify pathways, which were significantly positively correlated with the ADRs falls and haemorrhages, respectively. RESULTS: Regarding falls, CYP2D6, OCT2 and carboxylesterase 1 were identified as relevant metabolic pathways with cumulative inhibitory burden. Concerning haemorrhages, CYP2C19, CYP3A4, MRP4, OAT2, OATP1B1 and carboxylesterase 1 were determined. Within relevant pathways for the occurrence of falls, common fall-risk-increasing drugs (FRIDs) and associated drugs were found, as well as bleeding inducing drugs within relevant pathways for the occurrence of haemorrhages. CONCLUSION: Our approach identifies plausible inhibited pathways, raising awareness that a high burden of pathway inhibition can contribute to the occurrence of ADRs. Further validation in a second dataset is necessary.
引用
- Berres J, Wozniak J, Fölsch H, et al. The quantitative impact of metabolism-inhibiting drugs on the occurrence of adverse drug reactions-A backward selection approach. Br J Clin Pharmacol. 2026. PMID: 41721490. doi:10.1002/bcp.70494
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。